Please use this identifier to cite or link to this item:
https://biore.bio.bg.ac.rs/handle/123456789/6911
Title: | Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine | Authors: | Salehi, Bahare Selamoglu, Zeliha Mileski, Ksenija Pezzani, Raffaele Redaelli, Marco Cho, William C Kobarfard, Farzad Rajabi, Sadegh Martorell, Miquel Kumar, Pradeep Martins, Natália Subhra Santra, Tuhin Sharifi-Rad, Javad |
Keywords: | DepoCyt;cancer therapy;chemotherapy;liposomal ara-C;liposomal cytarabine;liposomal cytosine arabinoside | Issue Date: | 23-Nov-2019 | Journal: | Biomolecules | Volume: | 9 | Issue: | 12 | Start page: | 773 | Abstract: | Cancer is the second leading cause of death worldwide. The main modality to fight against cancer is surgery, radiotherapy, and chemotherapy, and more recently targeted therapy, gene therapy and immunotherapy, which play important roles in treating cancer patients. In the last decades, chemotherapy has been well developed. Nonetheless, administration of the drug is not always successful, as limited drug dosage can reach the tumor cells.. In this context, the possibility to use an encapsulated anti-cancer drug may potentially solve the problem. Liposomal cytarabine is a formulation with pronounced effectiveness in lymphomatous meningitis and reduced cardiotoxicity if compared to liposomal anthracyclines. Thus, the future liposomal cytarabine use could be extended to other diseases given its reduction in cytotoxic side effects compared to the free formulation. This review summarizes the chemistry and biology of liposomal cytarabine, with exploration of its clinical implications. |
URI: | https://biore.bio.bg.ac.rs/handle/123456789/6911 | ISSN: | 2218-273X | DOI: | 10.3390/biom9120773 |
Appears in Collections: | Journal Article |
Show full item record
SCOPUSTM
Citations
52
checked on Oct 31, 2024
Page view(s)
5
checked on Nov 4, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.